Neuroendocrine Carcinoma of the Bladder

• CLINICAL_TRIALS research · 2026-04-08
  Clinical Trial Update: Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial of the DLL3-targeting radiopharmaceutical [212Pb]Pb-DOTAM-MAM279 (MP0712) in small cell lung cancer and other DLL…

• CLINICAL_TRIALS trial_result · 2025-12-08
  Clinical Trial Update: Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma [Phase 2]

  Phase 2 study evaluating neoadjuvant adebrelimab plus etoposide and cisplatin for neuroendocrine carcinoma of the bladder, with recruitment …

• CLINICAL_TRIALS trial_result · 2019-06-20
  Clinical Trial Update: Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma [Phase 2, Phase 3]

  Clinical trial update for FOLFSIM Plus Toripalimab in advanced/metastatic neuroendocrine carcinoma of the bladder across Phase 2 and Phase 3…